收藏切换
Effects of triple lowering homocysteine on post-stroke congnitive impairment
收藏切换
Qiuju LI, Bin LIU, Yunyun ZHENG, Wenbo ZHANG, Fang YAN, Yuhui WANG*
World Clinical Drug | 2023, 44(9) : 959 - 965
Less
收藏切换
World Clinical Drug | 2023, 44(9): 959-965
• Article •
Effects of triple lowering homocysteine on post-stroke congnitive impairment
Full
Qiuju LI, Bin LIU, Yunyun ZHENG, Wenbo ZHANG, Fang YAN, Yuhui WANG*
Affiliations
  • Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China
Published: 2023-09-10 doi: 10.13683/j.wph.2023.09.011
Outline
收藏切换
Objective

To explore the relationship between blood homocysteine (Hcy) level and cognitive impairment in patients with acute ischemic stroke (AIS), and the effects of triple lowering Hcy by vitamin B12, folic acid and vitamin B6 on cognitive function.

Methods

A total of 74 initial AIS patients admitted to the department of neurology of Shanghai Punan hospital of Pudong new district were continuously enrolled. The patients were divided into hyperhomocysteinemia (HHcy) group (n=41, Hcy≥10 μmol/L) and low homocysteine (LHcy) group (n=33, Hcy<10 μmol/L) according to the blood Hcy level at the time of enrollment. Baseline cognitive function was assessed 7 days after enrollment. The patients in HHcy group were treated by oral 1 mg of mecobalamin, 5 mg of folic acid and 20 mg of vitamin B6 every day, and cognitive evaluation and blood Hcy levels were measured at 3, 6 and 12 months respectively after treatment. The differences in baseline vascular risk factors, cognitive score at baseline and changes of cognitive scores at follow-up were compared between the two groups.

Results

At baseline, the average blood Hcy levels in HHcy group and the LHcy group were (18.86±12.44) and (8.42±1.54) μmol/L, respectively. There were more male patients and smokers in the HHcy group, and the levels of blood folic acid and vitamin B12 were significantly lower than those of the LHcy group (P<0.01). The Montreal cognitive assessment scale (MoCA) score in HHcy group was significantly lower than that of the LHcy group (P<0.05). After 12 months of triple therapy of mecobalamin, folic acid, and vitamin B6, the blood Hcy level in the HHcy group were significantly reduced, the MoCA score was increased (P<0.01).

Conclusion

HHcy is a close but interventionable risk factor for post-stroke cognitive impairment. Triple Hcy lowering treatment can significantly reduce the Hcy level and may help to delay the cognitive decline in AIS patients.

homocysteine  /  acute ischemic stroke  /  post-stroke cognitive impairment
李秋菊, 刘斌, 郑贇贇, 张文波, 严芳, 王宇卉. 三联降同型半胱氨酸治疗对卒中后认知障碍的影响. 世界临床药物, 2023 , 44 (9) : 959 -965 . DOI: 10.13683/j.wph.2023.09.011
Qiuju LI, Bin LIU, Yunyun ZHENG, Wenbo ZHANG, Fang YAN, Yuhui WANG. Effects of triple lowering homocysteine on post-stroke congnitive impairment[J]. World Clinical Drug, 2023 , 44 (9) : 959 -965 . DOI: 10.13683/j.wph.2023.09.011
Year 2023 volume 44 Issue 9
13
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.09.011
  • Receive Date:2022-12-15
  • Online Date:2026-11-18
  • Published:2023-09-10
Article Data
Affiliations
History
  • Received:2022-12-15
Funding
Affiliations
    Department of Neurology, Shanghai Punan Hospital of Pudong New District, Shanghai 200125, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.09.011
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT